MedWatch
MedWatch is a Danish subscription-based online news platform covering pharmaceutical, biotech, medical device, and rehabilitation industries for healthcare professionals and investors, operating within the Watch Medier group under JP/Politikens Hus A/S.
- Company typePrivate
- Founded-
- HeadquartersCopenhagen, Denmark
- Headcount1–10
- GTM typeB2B and B2C
- OfferingDigital Commerce or Content
What MedWatch does
MedWatch is a Danish-language online news platform covering the pharmaceutical, biotech, medical device, and rehabilitation industries, serving healthcare and life-sciences professionals alongside healthcare-focused investors and financial analysts in Denmark and, via affiliated titles, the wider Nordic and English-language markets. The platform delivers daily news, analysis, regulatory updates, M&A coverage, results reporting, and personnel movements, with sections including "Medicinal & Biotek," "Medico & Rehab," "Digital sundhed," "Regulering & Samfund," and "Investor." Its product surface consists of a web platform (medwatch.dk), native iOS and Android applications, RSS feed syndication, and email newsletters, supported by editorial AI-usage, source-citation, and employee-investment disclosure guidelines and membership in the Danish Press Council (Pressenævnet).
The business is operated as a brand within the Watch Medier group, itself part of the larger JP/Politikens Hus A/S media conglomerate, and shares authentication and corporate subscription infrastructure with sister publications KapitalWatch (capital markets) and AdvokatWatch (legal), as well as affiliated MedWatch.no (Norway) and MedWatch.com (English). Revenue is generated through a subscription-based model with both individual and corporate tiers (sold via a dedicated enterprise portal at subscriptions.watchmedier.com), supplemented by banner advertising (ads.watchmedier.com), a vertical job board, and newsletter sponsorships. The asset is lean, with approximately 7 employees based at the Copenhagen headquarters at Rådhuspladsen 37, and is editorially led by Editor Ulrich Quistgaard and Editor-in-Chief Rasmus Emborg.
MedWatch firmographics
Firmographics- Name
- MedWatch
- Legal name
- MedWatch
- Website
- https://medwatch.dk
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MedWatch is a Danish subscription-based online news platform covering pharmaceutical, biotech, medical device, and rehabilitation industries for healthcare professionals and investors, operating within the Watch Medier group under JP/Politikens Hus A/S.
- Ownership category
- akta.pro rank
Where MedWatch is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
MedWatch business model
Business model- GTM type
- B2B and B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Subscription Revenue: MedWatch operates on a subscription-based model offering both individual and corporate subscriptions for access to pharmaceutical, biotech, and medical device industry news coverage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Individual subscription with access to all content |
Distribution channels4 records
Marketing channels4 records
MedWatch product offering
Product offeringCore offering
MedWatch operates a Danish-language subscription-based online news platform delivering specialized coverage of the pharmaceutical, biotech, medical device, and rehabilitation industries. The service is accessible via website, iOS and Android mobile applications, and RSS feeds, with individual and corporate subscription plans gating access to full editorial content.
Product overview
MedWatch is a Danish online news platform operated by Watch Medier, part of JP/Politikens Hus. The platform provides industry-specific journalism covering pharmaceutical, biotech, medico, rehabilitation, hearing aids, digital health, society, people, and disease/health topics. The core offering is the MedWatch News Platform, accessible via desktop and mobile web. The platform is complemented by native iOS and Android applications for mobile access, a subscription-based paywall model with individual and corporate plans, and RSS feed syndication for content distribution.
Differentiator
Problem solved
Functional benefit
Brands
- MedWatch: Danish news publication covering pharmaceutical, biotech, medical devices, and rehabilitation sectors
Products and services
- MedWatch News Platform Danish-language online news platform providing coverage of pharmaceutical, biotech, medico, and rehabilitation industries, featuring latest news articles, opinion pieces, regulatory updates, company results, and industry-specific reporting for healthcare professionals.
- MedWatch iOS App Native iOS mobile application providing access to MedWatch news content for Apple device users in the healthcare industry.
- MedWatch Android App Native Android mobile application providing access to MedWatch news content for Android device users in the healthcare industry.
- MedWatch Subscription Service Paid subscription service providing access to full MedWatch editorial content, with individual subscriptions and corporate/enterprise subscription plans available through a dedicated ordering portal.
- MedWatch RSS Feeds RSS feed service allowing users to subscribe to MedWatch news updates through standard RSS feed readers for automated content distribution.
Companies that use MedWatch
Customer profileSegments2 records
Ideal customer profiles2 records
MedWatch technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MedWatch partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Watch MediercoreMedWatch is part of the Watch Medier group, a specialized business media company within the JP/Politikens Hus portfolio. Watch Medier operates multiple industry-focused news publications including MedWatch (pharma/biotech/medico), KapitalWatch (capital markets), and AdvokatWatch (legal).
- JP/Politikens Hus A/ScoreMedWatch is published by JP/Politikens Hus A/S, one of Denmark's largest media groups. This ownership provides cross-media synergies and shared authentication infrastructure across JP/Politikens Hus publications.
- Pressenævnet (Press Council)minorMedWatch is a member of the Danish Press Council (Pressenævnet), demonstrating commitment to journalistic standards and press ethics compliance. The publication adheres to editorial guidelines regarding source verification, AI usage, and employee stock investments.
Recent moves6 records
Expansion highlights5 records
MedWatch competitors and assessment
Company assessmentDirect peers
- PharmaPhorum: Digital media platform for the pharmaceutical industry, with editorial content, industry features, and sponsored content. Direct peer on vertical digital media model serving pharma professionals, with a mix of advertising and content marketing revenue.
- MedCity News: Online news publication covering the business of healthcare and innovation, including pharma and digital health. Comparable as a B2B healthcare news outlet with advertising and event monetization, focused on a professional audience.
- BioSpace: Online community and news source for the biopharma industry with editorial coverage, job postings, and industry intelligence. Comparable to MedWatch on vertical specialization, multi-revenue-model B2B media (news + recruitment), and digital distribution.
- Fierce Pharma / Fierce Biotech: Industry trade news brands covering pharma and biotech, part of the Fierce Network. Direct peer in vertical coverage, B2B advertising + newsletter monetization, and digital-first distribution to pharma professionals.
- Drug Discovery & Development: Industry publication covering drug discovery, development, and pharmaceutical manufacturing. Comparable as a vertical B2B media brand in the pharma value chain, with online + newsletter distribution to professional readers.
- STAT News: Health and life sciences news site (owned by Boston Globe Media) covering pharma, biotech, and health policy. Comparable on subscription-driven digital news model, professional readership, and depth of life-sciences coverage, at significantly larger scale.
- Endpoints News: Subscription-based digital news outlet covering the biopharma industry with original reporting. Closely comparable to MedWatch on subscription model, vertical specialization, and digital-first distribution, with a global English-language audience.
- BioCentury: US-based B2B subscription news and analysis platform for the biotech industry. Most directly comparable to MedWatch in business model (paid subscriptions, professional audience) and vertical focus (biotech/pharma), though operating at larger scale in English.
Broad incumbents
- Citeline (Informa Pharma Intelligence): Pharma and clinical intelligence business within Informa, offering news, data, and analytics across the drug development lifecycle. Comparable to MedWatch in serving pharma/biotech professionals with paid intelligence, but as a much broader incumbent with data products beyond news.
Regional players
- Nordic Life Science News: Nordic-region news and media outlet covering life sciences, biotech, and medtech. Most directly comparable as a regional peer covering the same Nordic geography and life-sciences verticals that MedWatch targets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
MedWatch social profiles
Digital presenceMedWatch financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedWatch leadership team
Management profileNumber of profiles
Profiles2 records
MedWatch funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedWatch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedWatch
What does MedWatch do?
MedWatch operates a Danish-language subscription-based online news platform delivering specialized coverage of the pharmaceutical, biotech, medical device, and rehabilitation industries. The service is accessible via website, iOS and Android mobile applications, and RSS feeds, with individual and corporate subscription plans gating access to full editorial content.
Is MedWatch a public or private company?
MedWatch is a private company. It is classified as corporate owned and is currently operating.
When was MedWatch founded?
MedWatch was founded in -1. It employs 1 to 10 people.
Where is MedWatch based?
MedWatch is headquartered in Copenhagen, Denmark, in the Europe region.
How does MedWatch make money?
One revenue line is on record: subscription Revenue.
Who are MedWatch's main competitors?
Direct peers on record are PharmaPhorum, MedCity News, BioSpace, Fierce Pharma / Fierce Biotech, Drug Discovery & Development, STAT News, Endpoints News and BioCentury. Citeline (Informa Pharma Intelligence) is listed as a broad incumbent. Nordic Life Science News is listed as a regional player.
Does MedWatch have an API?
No public API is recorded for MedWatch.